Skip to main content
TipRanks
Go Ultimate75% OFF

Puma Biotechnology (PBYI) Ownership - Who Owns Puma Biotechnology?

680 Followers

Puma Biotechnology (PBYI) Ownership Overview

  • 15.78% Insiders
  • 16.21% Mutual Funds
  • 17.52% Other Institutional Investors
  • 18.33% ETFs
  • 32.16% Public Companies and Individual Investors

The ownership structure of Puma Biotechnology (PBYI) stock is a mix of institutional, retail, and individual investors. Approximately 52.06% of the company’s stock is owned by Institutional Investors, 15.78% is owned by Insiders, and 32.16% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 12, 2026Michael Patrick Miller$121,350
Nov 12, 2025Michael Patrick Miller$97,200

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Royce & Associates Llc$133,787
Sep 30, 2026Entrypoint Capital, Llc$345,127
Sep 30, 2026 $41,777,307

Top Shareholders

PBYI top shareholders
Holder# of SharesType% HoldingValue
Alan Auerbach7,261,671Insider14.05%56,423,184
BlackRock, Inc.4,207,181Institution8.14%32,689,796
Avantis2,825,128Institution5.46%21,951,245
Vanguard2,240,536Institution4.33%17,408,965
Ishares1,862,763Institution3.60%14,473,669
Vanguard Index Funds1,780,862Institution3.44%13,837,298
Dfa860,565Institution1.66%6,686,590
Vanguard Explorer Fund777,390Institution1.50%6,040,320
Dfa Investment Dimensions Group Inc771,194Institution1.49%5,992,177
Vanguard Horizon Funds607,581Institution1.18%4,720,904

Top Mutual Fund Holders

PBYI top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds1,780,862Institution3.44%13,837,298
Vanguard Explorer Fund777,390Institution1.50%6,040,320
Dfa Investment Dimensions Group Inc771,194Institution1.49%5,992,177
Vanguard Horizon Funds607,581Institution1.18%4,720,904
Bridgeway Funds, Inc.563,500Institution1.09%4,378,395
Fidelity Salem Street Trust548,536Institution1.06%4,262,125
Fidelity Concord Street Trust357,273Institution0.69%2,776,011
Vanguard Scottsdale Funds300,086Institution0.58%2,331,668
Russell Investment Co248,058Institution0.48%1,927,411
Blackrock Funds206,044Institution0.40%1,600,962

Top ETF Holders

PBYI top ETF holders
Holder# of SharesType% HoldingValue
Avantis U.S. Small Cap Value ETF, AVUV ETF2,556,827Institution4.95%20,659,162
Vanguard Total Stock Market ETF, VTI ETF1,343,121Institution2.60%13,337,192
iShares Russell 2000 ETF, IWM ETF1,177,767Institution2.28%9,151,250
Vanguard Extended Market ETF, VXF ETF460,043Institution0.89%4,568,227
Dimensional U.S. Targeted Value ETF, DFAT ETF384,736Institution0.74%3,108,667
Dimensional U.S. Small Cap ETF, DFAS ETF380,741Institution0.74%3,076,387
iShares Russell 2000 Value ETF, IWN ETF359,363Institution0.70%2,792,251
Vanguard Russell 2000 ETF, VTWO ETF257,267Institution0.50%2,554,661
EA Bridgeway Omni Small-Cap Value ETF, BSVO ETF248,990Institution0.48%2,011,839
Fidelity Enhanced Small Cap ETF, FESM ETF223,373Institution0.43%1,735,608

FAQ

Who Owns Puma Biotechnology (PBYI)?
According to the latest TipRanks data, approximately 52.06% of the company's stock is held by institutional investors, 15.78% is held by insiders, and 32.16% is held by public companies and individual investors.
What percentage of Puma Biotechnology (PBYI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.06% of Puma Biotechnology (PBYI) stock is held by institutional investors: 16.21% by mutual funds, 18.33% by ETFs and 17.52% by other institutional investors.
What percentage of Puma Biotechnology (PBYI) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.16% of Puma Biotechnology (PBYI) stock is held by public companies and individual investors.
Who owns the most shares of Puma Biotechnology (PBYI)?
Alan Auerbach owns the most shares of Puma Biotechnology (PBYI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.